We are live on
!
Find out more
M&G plc Portfolio holdings
AUM
$20.1B
Turnover
14.5%
1-Year Est. Return
16.62%
This Fund
S&P 500
This Quarter
Est. Return
-0.47%
1 Year Est. Return
+16.62%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.4B
AUM Growth
-$107M
(-0.55%)
Cap. Flow
-$6.32M
Cap. Flow
% of AUM
-0.03%
Top 10 Holdings %
Top 10 Hldgs %
31.82%
Holding
423
New
51
Increased
131
Reduced
125
Closed
43
Avg Time Held Equity + Options
1.3
years
Top 10 Avg Time Held Equity + Options
1.1
years
Top 20 Avg Time Held Equity + Options
1
year
Avg Time Held Equity only
1.3
years
Top 10 Avg Time Held Equity only
1.1
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$811M |
| 2 |
Microsoft
MSFT
|
+$183M |
| 3 |
Intuit
INTU
|
+$152M |
| 4 |
Broadcom
AVGO
|
+$130M |
| 5 |
The Magnum Ice Cream Company N.V.
MICC
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$190M |
| 2 |
Elevance Health
ELV
|
+$109M |
| 3 |
CME Group
CME
|
+$92.3M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$79.9M |
| 5 |
Huazhu Hotels Group
HTHT
|
+$67.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Healthcare | 16.38% |
| 3 | Consumer Discretionary | 15.42% |
| 4 | Financials | 11.36% |
| 5 | Communication Services | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Arista Networks
ANET
$225B
| $2.16M | 0.01% |
17,523
-98,904
| -85% | -$13.2M |
2024 Q1
8 quarters
|
|
277
Southern Company
SO
$104B
| $2.12M | 0.01% |
21,837
-1,015
| -4% | -$93.9K |
2025 Q3
2 quarters
|
|
278
Morgan Stanley
MS
$285B
| $2.08M | 0.01% |
12,635
| – | – |
2025 Q3
2 quarters
|
|
279
CrowdStrike
CRWD
$232B
| $2.07M | 0.01% |
+21,192
| New | +$2.25M |
2026 Q1
0 quarters
|
|
280
PepsiCo
PEP
$178B
| $1.99M | 0.01% |
12,867
| – | – |
2024 Q1
8 quarters
|
|
281
Alphabet (Google) Class C
GOOG
$4.14T
| $1.93M | 0.01% |
6,717
-727
| -10% | -$228K |
2024 Q3
6 quarters
|
|
282
Goldman Sachs
GS
$258B
| $1.91M | 0.01% |
2,253
-183
| -8% | -$163K |
2025 Q3
2 quarters
|
|
283
MetLife
MET
$64.4B
| $1.88M | 0.01% |
26,461
+9,123
| +53% | +$683K |
2024 Q2
7 quarters
|
|
284
S&P Global
SPGI
$126B
| $1.84M | 0.01% |
4,335
-131
| -3% | -$60.8K |
2024 Q1
8 quarters
|
|
285
IBM
IBM
$219B
| $1.73M | 0.01% |
7,130
+1,283
| +22% | +$347K |
2024 Q1
8 quarters
|
|
286
US Bancorp
USB
$90.8B
| $1.7M | 0.01% |
32,634
| – | – |
2024 Q1
8 quarters
|
|
287
Ferrari
RACE
$69.5B
| $1.69M | 0.01% |
4,986
| – | – |
2025 Q3
2 quarters
|
|
288
NXP Semiconductors
NXPI
$58.8B
| $1.68M | 0.01% |
8,533
-66,843
| -89% | -$14.8M |
2024 Q1
8 quarters
|
|
289
Palantir
PLTR
$449B
| $1.68M | 0.01% |
11,508
+7,342
| +176% | +$1.12M |
2025 Q3
2 quarters
|
|
290
Magna International
MGA
$17.9B
| $1.67M | 0.01% |
29,773
-32,392
| -52% | -$1.85M |
2024 Q1
8 quarters
|
|
291
Texas Instruments
TXN
$257B
| $1.6M | 0.01% |
8,223
| – | – |
2024 Q1
8 quarters
|
|
292
Biogen
BIIB
$34.8B
| $1.57M | 0.01% |
8,593
| – | – |
2024 Q1
8 quarters
|
|
293
Bright Horizons
BFAM
$3.45B
| $1.54M | 0.01% |
18,761
-650,520
| -97% | -$54.8M |
2024 Q1
8 quarters
|
|
294
Ormat Technologies
ORA
$5.55B
| $1.51M | 0.01% |
13,451
| – | – |
2025 Q4
1 quarter
|
|
295
Costco
COST
$439B
| $1.44M | 0.01% |
1,445
| – | – |
2025 Q3
2 quarters
|
|
296
GE Aerospace
GE
$327B
| $1.44M | 0.01% |
5,063
| – | – |
2025 Q3
2 quarters
|
|
297
Baker Hughes
BKR
$55.6B
| $1.33M | 0.01% |
+21,830
| New | +$1.26M |
2026 Q1
0 quarters
|
|
298
Honeywell
HON
$67.2B
| $1.25M | 0.01% |
5,528
| – | – |
2024 Q1
8 quarters
|
|
299
SLB Ltd
SLB
$73.7B
| $1.24M | 0.01% |
+24,231
| New | +$1.18M |
2026 Q1
0 quarters
|
|
300
Arbe Robotics
ARBE
$59.4M
| $1.22M | 0.01% |
1,219,379
| – | – |
2024 Q1
8 quarters
|
|
Similar funds
SA
BBA
M&G plc's Q1 2026 Portfolio in Review
As of Q1 2026, M&G plc held 423 positions worth $19.4B, down 0.55% from $19.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
M&G plc's Q1 2026 filing shows 51 new, 131 increased, 125 reduced and 43 closed positions. Its largest new stake was AstraZeneca: 4,204,199 shares worth $817M. The largest sale was Lam Research, an estimated $190M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- M&G plc's largest Q1 2026 buy was AstraZeneca: 4,204,199 shares worth $817M.
- M&G plc added most to Microsoft in Q1 2026, an estimated $183M increase.
- M&G plc's biggest Q1 2026 reduction was Lam Research, cutting an estimated $190M.
- M&G plc fully exited Crown Castle in Q1 2026, selling an estimated $34M.
- M&G plc's ten largest holdings make up 32% of its $19.4B portfolio in Q1 2026.
- M&G plc opened 51 new positions and closed 43 in Q1 2026.
- M&G plc's portfolio value fell 0.55% quarter-over-quarter to $19.4B.
Based on M&G plc's 13F filing for Q1 2026, filed 13 May 2026.